Phexxi -- A Non?Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy

Stock Information for Appili Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Appili Therapeutics Inc

Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update
Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference
Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store
Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting
Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1
Evofem Reports First Quarter 2025 Financial Results and Provides Business Update
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.